FDA Determines Regulatory Review Period for Detrol Patent Extension

Summary

The Food and Drug Administration (FDA) has officially confirmed the regulatory review period for Detrol, a human drug product, as required by law, following a patent extension application submitted to the Commissioner of Patents and Trademarks, Department of Commerce.